Good Manufacturing Practice (GMP) standards are essential for ensuring the quality and safety of pharmaceutical products globally. While core principles remain consistent, regional regulatory bodies periodically update their guidelines to address emerging challenges and technological advancements. Current GMP standards across major regions therefore are subject to change and future updates.

Lets start with the United States (US):

 

  • Current Standards: The Food and Drug Administration (FDA) enforces GMP through the Code of Federal Regulations (21 CFR Parts 210 and 211). The FDA has been emphasizing quality risk management and data integrity in recent guidance documents.  Check out the link below for more information

GMP Update: CDER Official Explains, Advises, and Predicts

  • Predicted Updates: Future updates may focus on incorporating artificial intelligence (AI) and machine learning (ML) in quality management systems, reflecting the industry’s shift towards digital transformation.  Stay in touch for other regional changes!